Foxp3^+^ regulatory T cells (T~reg~ cells) form a major population of CD4^+^ immunosuppressive T cells that plays a pivotal role in maintaining peripheral immune tolerance and preventing autoimmune diseases ([@bib31]). In addition, T~reg~ cells also restrain the immunity against foreign antigens and cancer. The development, maintenance, and function of T~reg~ cells are dependent on the master transcription factor Foxp3 and factors that regulate Foxp3 expression and function ([@bib17]). Genetic deficiencies in these core regulatory factors typically lead to impaired self-tolerance and homeostasis of T cells, coupled with severe autoimmune disorders. Strong evidence suggests that T~reg~ cells represent a diverse cell population, comprising functionally distinct subsets that control different types of immune responses ([@bib5]; [@bib17]). The molecular mechanism that regulates the differentiation and function of the diverse T~reg~ cells subsets remains poorly understood.

Recent studies have identified a specific subset of T~reg~ cells, the follicular T~reg~ cells (T~FR~ cells), which are localized in the B cell follicles and specialized for the control of germinal center (GC) reactions ([@bib8]; [@bib20]; [@bib36]). Formation of GCs is essential for various events of a T-dependent humoral immune response, such as antibody class switching, somatic hypermutation, and affinity maturation ([@bib25]). The GC reactions depend on follicular T helper cells (T~FH~ cells), a subset of CD4^+^ T effector cells which provide essential help to cognate B cells for their activation and differentiation in GCs ([@bib21]). The T~FR~ cells resemble the T~FH~ cells in that they express high levels of the chemokine receptor CXCR5, the inducible co-stimulator (ICOS), and the inhibitory receptor PD-1 ([@bib21]). However, in contrast to T~FH~ cells, the T~FR~ cells express Foxp3 and possess immunosuppressive function. It appears that the T~FR~ cells are generated from CXCR5^−^ T~reg~ cells, instead of naive T cells, in response to T cell--dependent antigens. The T~FR~ cell production requires the transcription factor Bcl-6 and is negatively regulated by the inhibitory receptor PD-1 ([@bib8]; [@bib20]; [@bib30]). However, the intracellular signaling events involved in the induction of T~FR~ cells are largely unknown.

The TNF receptor (TNFR)--associated factors (TRAFs) form a family of signaling adaptors that mediate signal transduction from both the TNFRs and various other immune receptors ([@bib12]). Among the TRAF family members, TRAF3 is particularly complex in signaling functions, which differ in the context of different receptors in different cell types ([@bib14]). In B cells, TRAF3 functions as a negative regulator of the noncanonical NF-κB signaling pathway and B cell survival. TRAF3 physically interacts with the NF-κB--inducing kinase (NIK) and mediates continuous degradation of this central component of the noncanonical NF-κB pathway ([@bib19]). Thus, loss of TRAF3 causes constitutive activation of noncanonical NF-κB, coupled with B cell hyperplasia and aberrant production of antibodies ([@bib13]; [@bib37]; [@bib11]). Similar abnormalities have been observed in B cell conditional transgenic mice expressing a stable form of NIK that lacks the TRAF3-binding motif (NIKΔT3; [@bib32]). In contrast to its negative role in B cell homeostasis, TRAF3 has a positive role in mediating TCR signaling and T cell--dependent immune responses ([@bib38]). Interestingly, the TRAF3 deficiency is associated with an increase in the frequency of T~reg~ cells, although the role of TRAF3 in regulating the homeostasis and function of T~reg~ cells remains unknown ([@bib14]; [@bib38]).

In the present study, we directly examined the function of TRAF3 in T~reg~ cells by generating T~reg~ cell--specific TRAF3 KO (*Traf3^Treg-KO^*) mice. We show that TRAF3 is dispensable for the homeostasis of the general population of T~reg~ cells. However, TRAF3 has a particularly important role in the regulation of T~FR~ cell generation and GC reactions. The T~reg~ cell--specific TRAF3 deficiency severely inhibited the antigen-stimulated production of T~FR~ cells, coupled with deregulated activation of T~FH~ cells and heightened GC reactions. Consequently, the *Traf3^Treg-KO^* mice have elevated production of high-affinity antibodies of the IgG subtypes. Mechanistically, TRAF3 is required for maintaining the high-level expression of ICOS in T~reg~ cells. We provide evidence that ICOS deficiency compromises the induction of T~FR~ cells and the control of GC reactions. These findings shed light on the signaling mechanism that mediates T~FR~ cell induction and identify TRAF3 as a crucial factor involved in this specific process.

RESULTS
=======

TRAF3 deficiency partially impaired the in vivo function of T~reg~ cells
------------------------------------------------------------------------

To study the function of TRAF3 in T~reg~ cells, we generated T~reg~-conditional TRAF3 KO mice by crossing the *Traf3*-floxed mice with Foxp3-Cre mice ([Fig. 1 A](#fig1){ref-type="fig"}). Ablation of TRAF3 did not reduce, but even moderately increased, the frequency of T~reg~ cells in the spleen ([Fig. 1 B](#fig1){ref-type="fig"}). To examine the effect of TRAF3 deficiency on the immunosuppressive function of T~reg~ cells, we performed in vitro suppression assays using T~reg~ cells purified from the spleen of WT and *Traf3^Treg-KO^* mice. The WT and TRAF3-deficient T~reg~ cells had comparable efficiencies in suppressing the proliferation of naive T cells ([Fig. 1 C](#fig1){ref-type="fig"}), suggesting a dispensable role for TRAF3 in regulating the in vitro function of T~reg~ cells.

![**T~reg~ cell--specific TRAF3 ablation does not reduce T~reg~ cell frequency but partially impairs the in vivo function of T~reg~ cells.** (A) T~reg~ (CD4^+^CD25^+^YFP^+^) and non-T~reg~ (CD4^+^CD25^−^YFP^−^) T cells were sorted from the WT-R26^YFP^ (WT) and *Traf3^Treg-KO^*R26^YFP^ (KO) mice, and TRAF3 expression was assessed by immunoblot. β-Actin served as a loading control. (B) The frequency of Foxp3^+^ T~reg~ cells (among CD3^+^CD4^+^ cells) in the spleen of WT and Traf3^Treg-KO^ (KO) mice (6 wk old) was assessed by flow cytometry; data are presented as mean ± SD of five mice per group. Data are representative of five independent experiments. (C) Naive CD4^+^ T cells (T~eff~) were labeled with CFSE and activated by anti-CD3 plus antigen-presenting cells (irradiated splenocytes from WT mice, depleted of CD3^+^ T cells) in the presence of the indicated ratios of WT or KO T~reg~ cells. Naive CD4^+^ T cell proliferation was measured as dilution of the cytosolic dye CFSE. Data are presented as a representative plot (left) and a summary graph (right) of six mice per genotype in three independent experiments. (D) *Rag1*-KO mice were adoptively transferred with WT B6.SJL CD45RB^hi^ naive CD4^+^ T cells (CD45.1^+^) along with either PBS buffer or sorted T~reg~ cells (CD45.1^−^), and body weight was monitored. (E and F) CD45RB^hi^ CD4^+^ T cells (CD45.1^+^) were transferred into recipient mice as in D (on week 5), and the total number (E) and frequency (F) of Th1 and Th17 cells in the spleen of the recipient mice were assessed by ICS. Eight mice in two different experiments were used for each group. (G and H) The frequency of adoptively transferred Foxp3^+^ T~reg~ cells (G) and IL-10--producing T~reg~ cells (gated on Foxp3^+^ cells) in the spleen of the recipient mice described in D was determined by flow cytometry (5 wk after adoptive transfer; H). (C--E, G, and H) Mean ± SD is shown. Data are representative of two independent experiments. \*, P \< 0.05; and \*\*, P \< 0.01.](JEM_20131019_Fig1){#fig1}

We next examined the in vivo function of T~reg~ cells using a well-defined adoptive transfer model, which involved cotransfer of CD45RB^hi^ naive CD4^+^ T cells with T~reg~ cells purified from the WT and *Traf3^Treg-KO^* mice. As expected, adoptive transfer of CD45RB^hi^ naive T cells into *Rag1*-KO mice induced severe body weight loss of the recipient mice, coupled with massive expansion of the transferred T cells, and these pathological phenotypes were efficiently blocked when the naive T cells were cotransferred with WT T~reg~ cells ([Fig. 1 D](#fig1){ref-type="fig"}). Compared with the WT T~reg~ cells, the TRAF3-deficient T~reg~ cells exhibited a reduced ability to suppress the expansion and pathological activity of the naive T cells ([Fig. 1, E and F](#fig1){ref-type="fig"}). Although the mutant T~reg~ cells remained fully functional in inhibiting the production of Th17 cells from the cotransferred naive CD4^+^ T cells, their ability to suppress the generation of Th1 cells was partially impaired ([Fig. 1 F](#fig1){ref-type="fig"}). After the adoptive transfer, a lower number of TRAF3-deficient T~reg~ cells was recovered compared with that of the WT T~reg~ cells ([Fig. 1 G](#fig1){ref-type="fig"}), suggesting reduced expansion or survival of the mutant T~reg~ cells. Furthermore, they showed a reduced level of IL-10 production ([Fig. 1 H](#fig1){ref-type="fig"}). Collectively, these data suggest that T~reg~ cell--specific TRAF3 deficiency does not compromise the homeostasis or in vitro function of T~reg~ cells but partially impairs the in vivo functions of T~reg~ cells.

Altered CD4 T cell homeostasis in *Traf3^Treg-KO^* mice
-------------------------------------------------------

To assess the function of the TRAF3-deficient T~reg~ cells under nontransferred conditions, we examined the homeostasis of CD4^+^ T cells in peripheral lymphoid organs. The spleens and lymph nodes of the *Traf3^Treg-KO^* mice contained an enhanced frequency of CD4^+^ T cells with memory-like markers (CD44^hi^CD62L^lo^; [Fig. 2, A and B](#fig2){ref-type="fig"}). Among the memory-like CD4^+^ T cells in the peripheral lymphoid organs, there was a significant increase in the frequency of IFN-γ--producing Th1 cells in the *Traf3^Treg-KO^* mice, although the frequency of Th17 cells was generally low and not significantly different between the WT and mutant mice ([Fig. 2 C](#fig2){ref-type="fig"}).

![**Altered CD4^+^ T cell homeostasis in *Traf3^Treg-KO^* mice.** (A--D) Spleens (A--C; *n* = 4--5) or small and large intestine lamina propria (D; *n* = 6) were harvested from 8-wk-old WT or *Traf3^Treg-KO^* (KO) mice and analyzed by flow cytometry for the frequency (A) and absolute number (B) of memory-like (CD44^hi^CD62L^lo^) CD4^+^ T cells, and the frequency of IL-17-- and IFN-γ--producing CD4^+^ T cells (C and D) was assessed using ICS. Mean ± SD is shown. Data are representative of five independent experiments. \*, P \< 0.05.](JEM_20131019_Fig2){#fig2}

T~reg~ cells play an important role in maintaining T cell homeostasis in the intestine, an organ with dynamic interactions between the immune system and microbiota ([@bib22]). The T~reg~ cell--specific TRAF3 deficiency resulted in a moderate increase in the frequency of CD4^+^ T cells, but not the CD8^+^ T cells, in the lamina propria of the small and large intestines (not depicted). Among the CD4^+^ T cells, there was a significantly increased frequency of Th1 cells in the lamina propria of *Traf3^Treg-KO^* mice ([Fig. 2 D](#fig2){ref-type="fig"}). Thus, the loss of TRAF3 in T~reg~ cells altered the homeostasis of T cells, a finding which was consistent with the partially compromised function of the TRAF3-deficient T~reg~ cells ([Fig. 1, D--F](#fig1){ref-type="fig"}). It is important to note, however, that the overall phenotype of the *Traf3^Treg-KO^* mice in T cell homeostasis was considerably milder compared with that observed in mutant mice lacking Foxp3 or its major regulators that mediate the development and core functions of T~reg~ cells ([@bib17]). Moreover, the *Traf3^Treg-KO^* mice only displayed relatively mild tissue inflammation at older ages, mostly seen in the lung and the liver (not depicted). These results suggest that TRAF3 may regulate a specific function, instead of mediating the core suppressive activity, of T~reg~ cells.

T~reg~ cell--specific TRAF3 controls antigen-stimulated humoral immune responses
--------------------------------------------------------------------------------

In addition to maintaining T cell homeostasis and preventing autoimmune diseases, T~reg~ cells play an important role in modulating immune responses to foreign antigens. To examine the role of TRAF3 in mediating this latter function of T~reg~ cells, we analyzed the effect of T~reg~ cell--specific TRAF3 deficiency on the induction of antibodies by well-characterized protein and nonprotein antigens. Upon immunization of a protein antigen, sheep RBCs (SRBCs), the young *Traf3^Treg-KO^* and WT control mice produced comparable levels of IgM (not depicted). However, the *Traf3^Treg-KO^* mice produced significantly more IgG and its subtypes ([Fig. 3 A](#fig3){ref-type="fig"}). Similar results were obtained when the mice were immunized with another protein antigen composed of the hapten 4-hydroxy-3-nitrophenylacetyl (NP) conjugated to the carrier protein KLH (NP-KLH; [Fig. 3 B](#fig3){ref-type="fig"}). ELISA assays using NP9-BSA (for high affinity) and NP26-BSA (for global affinity) suggested that the T~reg~ cell--specific TRAF3 ablation particularly enhanced the production of high-affinity antibodies ([Fig. 3 B](#fig3){ref-type="fig"} and not depicted). In response to immunization by a nonprotein antigen, NP-Ficoll, the production of high-affinity IgG, mainly IgG2b, was only moderately enhanced in the *Traf3^Treg-KO^* mice ([Fig. 3 C](#fig3){ref-type="fig"}).

![**T~reg~ cell--specific TRAF3 controls antigen-stimulated humoral immune responses.** (A) WT and *Traf3^Treg-KO^* mice (8 wk old) were immunized i.p. with SRBCs, and serum SRBC--specific Ig was measured 14 d later by ELISA (*n* = 5). (B and C) WT and *Traf3^Treg-KO^* mice (6--8 wk old) were immunized i.p. with KLH-NP26 (B) or Ficoll-NP26 for 12 d (C), and NP9 (high affinity) Ig was measured 12 d later by ELISA (B: *n* = 4; C: *n* = 9). (D) Basal concentrations of Ig isotypes and IgG subclasses in the sera of 18--20-wk-old WT and *Traf3^Treg-KO^* mice were measured by ELISA (*n* = 7). (E and F) WT and *Traf3^Treg-KO^* mice (8 wk old; *n* = 10) were intranasally infected with influenza virus H1N1 and monitored for bodyweight loss (E) and serum anti-H1N1 IgG antibody titer on day 13 (F). (A--F) Mean ± SD is shown. Data are representative of four (A--D) or two (E and F) independent experiments. \*, P \< 0.05; and \*\*, P \< 0.01.](JEM_20131019_Fig3){#fig3}

We also examined the effect of TRAF3 deficiency on the basal level of antibodies in different ages of mice. At a young age, the WT and *Traf3^Treg-KO^* mice had comparable serum concentrations of antibodies (not depicted). However, older *Traf3^Treg-KO^* mice (18--20 wk old) had an elevated basal level of serum IgG, particularly IgG1 and IgG2b ([Fig. 3 D](#fig3){ref-type="fig"}). These results suggest that expression of TRAF3 in T~reg~ cells is important for controlling the magnitude of humoral immune responses, especially the production of high-affinity IgG antibodies.

To further assess the role of T~reg~ cell--specific TRAF3 in mediating humoral immune responses, we used a model of influenza infection, which is known to trigger strong T cell--dependent antibody responses ([@bib9]). As expected, the WT mice experienced bodyweight loss after the intranasal infection with the A/PR8 (H1N1) strain of influenza virus ([Fig. 3 E](#fig3){ref-type="fig"}). Importantly, under the same infection conditions, the *Traf3^Treg-KO^* mice had much less bodyweight reduction compared with the WT mice ([Fig. 3 E](#fig3){ref-type="fig"}). Moreover, the *Traf3^Treg-KO^* mice also produced significantly higher levels of antiviral IgG antibodies ([Fig. 3 F](#fig3){ref-type="fig"}). These results emphasize the biological significance of the TRAF3-mediated T~reg~ cell regulation.

T~reg~ cell--specific TRAF3 regulates T~FH~ cell function and GC formation
--------------------------------------------------------------------------

A hallmark of T cell--dependent antibody responses is the formation of GCs, which are required for various events of the humoral immune response, including antibody class switching, somatic hypermutation, and affinity maturation ([@bib25]). Because the T~reg~ cell--specific TRAF3 deficiency preferentially promoted the production of high-affinity antibodies of a major secondary isotype, IgG, we examined the role of TRAF3 in regulating GC formation by flow cytometry, based on the typical surface markers of GC B cells. As expected, immunization of the WT animals with SRBCs induced production of GC B cells, which peaked around 1 wk and declined around 2 wk after the immunization ([Fig. 4 A](#fig4){ref-type="fig"}). Importantly, the *Traf3^Treg-KO^* mice produced a markedly higher frequency of GC B cells than the WT mice ([Fig. 4, A and B](#fig4){ref-type="fig"}). Parallel immunofluorescence assays also revealed the formation of enlarged GCs in the spleen of the *Traf3^Treg-KO^* mice after SRBC immunization ([Fig. 4 C](#fig4){ref-type="fig"}).

![**T~reg~ cell--specific TRAF3 regulates T~FH~ cell function and GC formation.** (A and B) WT and *Traf3^Treg-KO^* (KO) mice (8 wk old) were immunized i.p. with SRBCs, and the frequency of GC B cells (CD95^+^GL7^+^) among B220^+^ cells was assessed by flow cytometry. Data are presented as a representative plot (A) and mean ± SD based on five mice for each group (B). (C) Mice were immunized as in A and B, and GCs were analyzed by immunofluorescence detection of PNA^+^ cells. Graph shows average GC areas as mean ± SD based on multiple slides. Data are representative of four WT and three *Traf3^Treg-KO^* (KO) mice. Bars, 500 µm. (D) Frequency of W33 to L mutation in the GC B cells of SRBC-immunized WT and *Traf3^Treg-KO^* mice (10 d after immunization), determined by sequencing the cDNA clones constructed using pooled RNA from six WT and six KO mice. (E and F) WT-R26^YFP^ (WT) or *Traf3^Treg-KO^*R26^YFP^ (KO) mice were immunized as in A, and 10 d later, the frequency of T~FH~ cells (CXCR5^+^PD-1^+^) among CD4^+^YFP^−^ T cells was assessed by flow cytometry. Data are presented as a representative plot (E) and mean ± SD (F) based on six mice for each group. (G) T~FH~ cells were sorted from the spleens of the WT and KO mice in E and F, and expression of the indicated genes was assessed by RT-PCR. Mean ± SEM is shown. Data in A--G are representative of three to four independent experiments. \*, P \< 0.05; and \*\*, P \< 0.01.](JEM_20131019_Fig4){#fig4}

Formation of GCs is associated with antibody somatic hypermutations, a mechanism which generates high-affinity antibodies ([@bib1]; [@bib35]). Given the enhanced GC formation in *Traf3^Treg-KO^* mice, we analyzed the antibody somatic hypermutation frequency in the immunized WT and *Traf3^Treg-KO^* mice based on the tryptophan (W) 33 to leucine (L) hotspot mutation in the Ig heavy chain variable gene V~H~186.2 ([@bib2]). Consistent with the elevated GC formation in the *Traf3^Treg-KO^* mice, these mutant animals had a profoundly higher frequency of W33 to L mutations ([Fig. 4 D](#fig4){ref-type="fig"}).

GC formation and antibody class switching are dependent on T~FH~ subtype of CD4^+^ helper T cells. We found that in response to SRBC immunization, the WT and *Traf3^Treg-KO^* mice produced a comparable frequency of T~FH~ cells ([Fig. 4, E and F](#fig4){ref-type="fig"}). Interestingly, however, the T~FH~ cells derived from the *Traf3^Treg-KO^* mice displayed hyperexpression of genes encoding several cytokine genes, including IL-4, IL-10, IL-17, and IFN-γ ([Fig. 4 G](#fig4){ref-type="fig"}). Furthermore, the expression of several transcription factors, such as Bcl-6, Gata-3, and RORγt, were also elevated in the T~FH~ cells derived from the immunized *Traf3^Treg-KO^* mice ([Fig. 4 G](#fig4){ref-type="fig"}). Of note, T~FH~ cells are known to produce different effector cytokines depending on the nature of antigens, which appears to influence the antibody class switching in a humoral immune response ([@bib3]; [@bib21]). Several of these cytokines, IL-4, IL-17, and IFN-γ, have been shown to mediate B cell help and induction of antibody class switching toward the generation of different IgG subtypes ([@bib3]; [@bib23]; [@bib21]). Thus, the perturbed T~FH~ cell activation provided explanations for the aberrant formation of GCs and hyper production of IgG isotypes in *Traf3^Treg-KO^* mice.

TRAF3 is important for T~FR~ cell induction
-------------------------------------------

Recent studies identified a subset of T~reg~ cells, the T~FR~ cells, which controls the function of T~FH~ cells and GC reactions ([@bib8]; [@bib20]; [@bib36]). T~FR~ cells are characterized by expression of the chemokine receptor CXCR5, which mediates their migration into the lymphoid follicles ([@bib21]). In addition, the T~FR~ cells also express high levels of the co-inhibitory molecule PD-1 and the transcription factor Bcl-6, respectively exerting negative and positive roles in T~FR~ regulation ([@bib8]; [@bib20]; [@bib36]; [@bib30]).

The particularly prominent phenotype of the *Traf3^Treg-KO^* mice in T~FH~ cell activation and humoral immune responses prompted us to examine the induction and function of T~FR~ cells. We analyzed the T~FR~ cells based on their surface expression of CXCR5 and PD-1 within the population of GFP^+^ (expressed from the Foxp3-GFP-hCre transgene) T~reg~ cells. As expected, the spleens of the WT mice contained a small population of CXCR5^+^PD-1^+^GFP^+^ T~FR~ cells, and this population was significantly increased in response to SRBC immunization ([Fig. 5, A and B](#fig5){ref-type="fig"}). Under unimmunized conditions, the T~FR~ frequency of the *Traf3^Treg-KO^* mice was only moderately lower than that of the WT mice ([Fig. 5, A and B](#fig5){ref-type="fig"}). However, these mutant animals were attenuated in antigen-stimulated production of T~FR~ cells after SRBC immunization ([Fig. 5, A and B](#fig5){ref-type="fig"}). To further confirm this remarkable result, we stained the T~FR~ cells based on their surface expression of CXCR5 and intracellular expression of Bcl-6 and Foxp3. This method once again revealed a defect of the *Traf3^Treg-KO^* mice in T~FR~ cell production in response to immunization with SRBCs ([Fig. 5, C and D](#fig5){ref-type="fig"}). Thus, although TRAF3 is dispensable for the homeostasis of T~reg~ cells, it is important for the induction of a specific subset of T~reg~ cells, the T~FR~ cells, involved in the control of GC formation and humoral immune responses. This finding explains the aberrant induction of GCs and high-affinity antibodies in the *Traf3^Treg-KO^* mice.

![**TRAF3 is required for T~FR~ cell induction.** (A and B) WT-R26^YFP^ and *Traf3^Treg-KO^*-R26^YFP^ (KO) mice (8 wk old) were immunized with SRBCs, and 10 d later, the frequency of T~FR~ cells (CXCR5^+^PD-1^+^YFP^+^CD4^+^) in the spleen was assessed by flow cytometry. Data are presented as a representative plot (A) and mean ± SD (B) based on eight WT and nine KO mice. (C and D) Mice were immunized as in A and B, and the frequency and absolute number of T~FR~ cells was assessed by flow cytometry based on surface staining of CXCR5 and intracellular staining of Bcl-6 within Foxp3^+^CD4^+^ T~reg~ cells. Data are presented as a representative plot (C) and mean ± SD (D) based on eight WT and nine KO mice. (A--D) Data are representative of three to four independent experiments.\*, P \< 0.05; and \*\*, P \< 0.01.](JEM_20131019_Fig5){#fig5}

TRAF3 mediates ICOS gene expression in T~reg~ cells
---------------------------------------------------

To assess the molecular mechanism by which TRAF3 regulates T~reg~ cell function, we examined the expression of signature molecules on WT and TRAF3-deficient T~reg~ cells. Although the TRAF3 deficiency did not affect the expression of most of the T~reg~ cell surface markers analyzed, it caused an increase in the frequency of CD103^hi^ T~reg~ cell populations ([Fig. 6 A](#fig6){ref-type="fig"}). The increase in CD103^hi^ T~reg~ cells might be caused by their elevated activation, as expression of this molecule is known to be associated with effector/memory type T~reg~ cells ([@bib15]). Interestingly, the TRAF3-deficient T~reg~ cells had a profound reduction in the expression level of ICOS ([Fig. 6 A](#fig6){ref-type="fig"}), a co-stimulatory molecule thought to mediate specific T~reg~ cell functions, such as IL-10 gene induction and T~FR~ cell development ([@bib16]; [@bib4]; [@bib26]; [@bib30]). QPCR analysis further confirmed the defect in *Icos* gene expression ([Fig. 6 B](#fig6){ref-type="fig"}). Moreover, the TRAF3-deficient T~reg~ cells were also impaired in the induction of IL-10 expression ([Fig. 6, B--D](#fig6){ref-type="fig"}). These findings further suggest the involvement of TRAF3 in the regulation of specific aspects of T~reg~ cell functions.

![**TRAF3 mediates ICOS gene expression via a MAP kinase pathway in T~reg~ cells.** (A) Expression of the indicated surface markers on Foxp3^+^CD4^+^ T~reg~ cells from the spleens of WT and *Traf3^Treg-KO^* mice (6 wk old) was assessed by flow cytometry. (B) Expression of the indicated genes in T~reg~ cells from 6-wk-old WT or *Traf3^Treg-KO^* (KO) mice was assessed by RT-PCR. Mean ± SEM is shown. (C) The frequency of IL-10--producing cells among YFP^+^CD4^+^ T~reg~ cells from the spleen of WT-R26^YFP^ (WT) and *Traf3^Treg-KO^*-R26^YFP^ (KO) mice was assessed by flow cytometry. Data are presented as a representative plot (left) and the mean ± SD of six mice for each group. The left panel of C shows the isotype control for IL-10 ICS. (D) GFP^+^CD25^+^CD4^+^ T~reg~ cells were sorted from the spleens of three WT and three KO mice and stimulated for 24 h with PMA and ionomycin. IL-10 secretion was measured by ELISA. (E and F) WT or *Traf3^Treg-KO^* (KO) mice (6 wk old; *n* = 5) were immunized with SRBCs, and 10 d later, ICOS expression in T~FR~ (E) or T~FH~ (F) cells was assessed by flow cytometry. Graph in E shows the mean fluorescence intensity (MFI) of ICOS based on five mice for each group. (D--F) Mean ± SD is shown. (G) *Rag1*-KO recipient mice were adoptively transferred with 1:1 ratio of mixed bone marrows of WT (B6.SJL, CD45.1^+^) and *Traf3^Treg-KO^* (KO, CD45.2^+^) mice. 6 wk later, mice were immunized with SRBCs, and ICOS expression on gated WT (CD4^+^CD45.1^+^Foxp3^+^) and KO (CD4^+^CD45.2^+^Foxp3^+^) T~reg~ cells was assessed by flow cytometry at day 10 after immunization. Graph shows MFI as mean ± SD from four mice for each group. Data are representative of three to four (A--F) or two (G) independent experiments. \*, P \< 0.05; and \*\*, P \< 0.01.](JEM_20131019_Fig6){#fig6}

Because *Traf3^Treg-KO^* mice had a defect in T~FR~ cell induction, we tested whether TRAF3 was required for antigen-stimulated ICOS expression on T~FR~ cells. As seen with the total T~reg~ cells, ICOS expression was reduced on T~FR~ cells under unimmunized conditions ([Fig. 6 E](#fig6){ref-type="fig"}). Importantly, the defect of the TRAF3-deficient T~FR~ cells in ICOS expression became much more drastic after immunization of the mice with the protein antigen SRBCs ([Fig. 6 E](#fig6){ref-type="fig"}). Furthermore, this defect appeared to be cell intrinsic because it was not detected in the Foxp3^−^ non-T~reg~ cells ([Fig. 6 F](#fig6){ref-type="fig"}). A mixed bone marrow adoptive transfer experiment revealed that the TRAF3-deficient T~reg~ cells had reduced ICOS expression even when they were developed in the presence of WT T~reg~ cells in the same recipient mice ([Fig. 6 G](#fig6){ref-type="fig"}), thus further suggesting a cell-intrinsic role for TRAF3 in the regulation of ICOS expression in T~reg~ cells.

NIK overexpression does not inhibit ICOS expression
---------------------------------------------------

The signaling function of TRAF3 is complex and may vary among cell types ([@bib14]). TRAF3 is known to bind to NIK and mediate NIK degradation, thereby negatively regulating the noncanonical NF-κB signaling ([@bib33]). Loss of TRAF3 causes accumulation of NIK and constitutive activation of noncanonical NF-κB in B cells and T cells ([@bib19]; [@bib13]; [@bib37]; [@bib11]). To examine how TRAF3 regulates ICOS expression, we examined the potential involvement of noncanonical NF-κB activation. We used a transgenic mouse expressing a stabilized form of NIK lacking its TRAF3-binding motif (NIKΔT3) under the control of a *lox*P-flanked stop cassette ([@bib32]). By crossing these mice with the Foxp3-GFP-hCre mice, we generated T~reg~-conditional NIKΔT3 transgenic (NIKΔT3^Treg-Tg^) mice. As seen with the *Traf3^Treg-KO^* mice, the NIKΔT3^Treg-Tg^ mice displayed a moderate increase in memory-like effector T cells ([Fig. 7 A](#fig7){ref-type="fig"}). This result suggested that deregulated noncanonical NF-κB activation might partially impair the function of T~reg~ cells. However, the NIKΔT3^Treg-Tg^ mice did not show obvious abnormalities in antibody responses ([Fig. 7 B](#fig7){ref-type="fig"}) or reduced expression of ICOS and IL-10 in T~reg~ cells ([Fig. 7, C and D](#fig7){ref-type="fig"}). In fact, the level of ICOS was even slightly enhanced in these mutant T~reg~ cells ([Fig. 7 C](#fig7){ref-type="fig"}), probably reflecting their abnormal activation. Consistent with this idea, another activation marker, CD103, was also enhanced on the NIKΔT3 T~reg~ cells ([Fig. 7 E](#fig7){ref-type="fig"}).

![**NIK overexpression in T~reg~ cells does not inhibit the expression of ICOS and IL-10 or perturb antibody production.** (A) The frequency of memory (CD44^hi^CD62L^lo^) and naive (CD44^lo^CD62L^hi^) CD4^+^ T cells in WT and NIKΔT3^Treg-Tg^ mice (12 wk old; *n* = 4) was analyzed by flow cytometry. (B) Serum IgM and IgG in unmanipulated WT and NIKΔT3^Treg-Tg^ mice (12--16 wk old; *n* = 4) was measured by ELISA. (C) Expression of ICOS in CD4^+^Foxp3^+^ T cells from WT and NIKΔT3^Treg-Tg^ mice (6 wk old; *n* = 3) was assessed by flow cytometry. (D) Frequency of IL-10--producing cells among GFP^+^CD4^+^ T~reg~ cells from the spleen of WT and NIKΔT3^Treg-Tg^ mice (6 wk old; *n* = 3) was measured by ICS. (B and D) Mean ± SD is shown. (E) Expression of the indicated surface markers on Foxp3^+^CD4^+^ T~reg~ cells from the spleens of WT and NIKΔT3^Treg-Tg^ mice (8 wk old) was assessed by flow cytometry. Data are representative of four independent experiments.](JEM_20131019_Fig7){#fig7}

TRAF3-mediated ICOS induction involves activation of ERK and AP1
----------------------------------------------------------------

In conventional T cells, TRAF3 has a role in mediating TCR-stimulated activation of the MAP kinase ERK ([@bib38]). We found that loss of TRAF3 in T~reg~ cells also inhibited the activation of ERK by the TCR and CD28 signals ([Fig. 8 A](#fig8){ref-type="fig"}). To test whether attenuated ERK activation contributed to the reduced expression of ICOS in T~reg~ cells, we used a selective ERK inhibitor, U0126. Indeed, the ERK inhibitor severely inhibited the induction of ICOS expression ([Fig. 8 B](#fig8){ref-type="fig"}). ICOS promoter contains an AP1-binding site that is important for promoter activation by the TCR/CD28 signals ([@bib34]). Consistently, we found that cross-linking the TCR and CD28 in WT T cells led to rapid activation of AP1 that bound to the ICOS AP1 probe ([Fig. 8 C](#fig8){ref-type="fig"}). Moreover, the TRAF3 deficiency attenuated the activation of AP1 ([Fig. 8 C](#fig8){ref-type="fig"}). These findings suggest that TRAF3 regulates ICOS gene induction via an ERK--AP1 signaling pathway.

![**TRAF3 mediates TCR/CD28-stimulated activation of ERK and AP1.** (A) T~reg~ cells (CD4^+^YFP^+^CD25^+^) were sorted from WT-R26^YFP^ and Traf3^Treg-KO^-R26^YFP^ mice and stimulated for the indicated time periods with anti-CD3 plus anti-CD28 using a cross-linking method. Levels of total and phosphorylated ERK1,2 were assessed by immunoblot. Data are presented as a representative blot (left) and a summary graph based on quantification of three independent blots (right). Mean ± SD is shown. (B) ICOS expression on sorted WT T~reg~ cells that were either not treated (NT) or treated with anti-CD3 plus anti-CD28 in the absence (T) or presence (T + U0126) of an ERK inhibitor, 50 µM U0126, for 24 h was assessed by flow cytometry. (C) Nuclear extracts were prepared from WT or TRAF3-deficient CD4^+^ T cells stimulated with anti-CD3 plus anti-CD28 for the indicated time periods, and EMSA was performed using ICOS AP1 or the control NF-Y oligonucleotide probes. Data are representative of three independent experiments. \*\*, P \< 0.01.](JEM_20131019_Fig8){#fig8}

ICOS expression in T~reg~ cells is required for the formation and function of T~FR~ cells
-----------------------------------------------------------------------------------------

A recent study suggests that *Icos*-KO mice have a defect in T~FR~ cell induction, although it is unclear whether this function is cell intrinsic ([@bib30]). We used a T~reg~ cell adoptive transfer model to examine whether the expression of ICOS in T~reg~ cells is required for the development and function of T~FR~ cells. We adoptively transferred the T cell--deficient *Tcrb*/*Tcrd* double KO (*Tcrb*/*Tcrd*-dKO) mice with WT naive CD4^+^ T cells together with T~reg~ cells purified from WT, *Traf3^Treg-KO^*, or *Icos*-KO mice and then challenged the mice with SRBC antigen. The different T~reg~ cells were highly similar in homeostasis after the adoptive transfer ([Fig. 9 A](#fig9){ref-type="fig"}). In contrast, although the WT T~reg~ cells efficiently suppressed the induction of GCs in the immunized recipient mice, the TRAF3-deficient T~reg~ cells were largely defective in this function ([Fig. 9 B](#fig9){ref-type="fig"}). The similar deficiency was observed with the ICOS-deficient T~reg~ cells ([Fig. 9 B](#fig9){ref-type="fig"}).

![**ICOS is essential for controlling T~FH~ cell function and GC formation.** Sorted naive CD4^+^ T cells (CD4^+^CD62L^hi^CD44^lo^CD25^−^) from WT B6.SJL mice (5 wk old; CD45.1^+^) and sorted T~reg~ T cells (CD4^+^YFP^+^CD25^+^) from WT, *Traf3^Treg-KO^* (*Traf3*-KO), or *Icos*-KO mice (6 wk old; CD45.2^+^) were mixed in a 5:1 ratio and intravenously transferred into *Tcrb*/*Tcrd*-dKO mice. 2 d later, recipient mice were immunized with SRBCs and sacrificed for experiments 14 d after immunization. (A) Frequency of T~reg~ cells (CD45.1^−^) and naive CD4^+^ T cells (CD45.1^+^) in the spleen of *Tcrb*/*Tcrd*-dKO recipients was assessed by flow cytometry. (B) Frequency of GC B cells (GL7^+^CD95^+^) among B220^+^ cells was assessed by flow cytometry. Data are presented as a representative plot (left) and mean ± SD (right) based on three mice for each group. (C) SRBC-specific antibody levels in the sera of *Tcrb*/*Tcrd*-dKO recipient mice transferred with WT, *Traf3*-KO, and *Icos*-KO T~reg~ cells was assessed by ELISA. Mean ± SD is shown. (D) Frequency of plasma cells (B220^−^CD138^+^) in the spleens of the *Tcrb*/*Tcrd*-dKO recipients was assessed by flow cytometry. (E and F) Frequency of the T~FH~ (CXCR5^+^PD-1^+^Foxp3^−^CD4^+^) cells among CD4^+^Foxp3^−^ T cells (E) and the frequency of T~FR~ (CXCR5^+^PD-1^+^GFP^+^CD4^+^) cells among CD4^+^Foxp3^+^ T~reg~ cells (F) were assessed by flow cytometry. Data are presented as mean ± SD based on three mice for each group and are representative of two independent experiments. \*, P \< 0.05; \*\*, P \< 0.01; and \*\*\*, P \< 0.001.](JEM_20131019_Fig9){#fig9}

We next examined the production of high-affinity IgG antibodies in the immunized recipient mice. Consistent with the deficiency of the *Traf3*-KO and *Icos*-KO T~reg~ cells in suppressing the GC formation, they also displayed attenuated function in the control of IgG production compared with the WT T~reg~ cells ([Fig. 9 C](#fig9){ref-type="fig"}). Moreover, the recipient mice of *Traf3*-KO and *Icos*-KO T~reg~ cells contained substantially higher levels of plasma cells ([Fig. 9 D](#fig9){ref-type="fig"}) and T~FH~ cells ([Fig. 9 E](#fig9){ref-type="fig"}), coupled with reduced frequency of T~FR~ cells ([Fig. 9 F](#fig9){ref-type="fig"}). Collectively, these data suggest that TRAF3 and ICOS have a T~reg~ cell--intrinsic role in mediating the generation and function of T~FR~ cells.

DISCUSSION
==========

The Foxp3^+^ T~reg~ cells represent a functionally diverse population composed of subsets that regulate different immune functions ([@bib5]; [@bib17]). The signaling mechanism that regulates the functional diversity of T~reg~ cells is still poorly understood. In the present study, we have identified TRAF3 as a signaling factor that mediates the effector function of T~reg~ cells, particularly their control of GC formation and antibody responses. Our data suggest that TRAF3 is involved in the induction of the recently defined T~FR~ cells, a subset of T~reg~ cells specialized in the control of GC reactions ([@bib8]; [@bib20]; [@bib36]). Consequently, the mice with T~reg~ cell--specific TRAF3 deficiency display heightened responses to antigens in the formation of GCs and production of high-affinity antibodies.

A recent study suggests that TRAF3 ablation in total T cells, by crossing the *Traf3*-floxed mice with CD4-Cre mice, causes an increase in the percentage of Foxp3^+^ T~reg~ cells ([@bib38]). Because TRAF3 is knocked out during the double-positive stage of thymocyte development in this approach, it is thought that TRAF3 may regulate the development of T~reg~ cells ([@bib14]). Our present study revealed that ablation of TRAF3 in committed T~reg~ cells, using the Foxp3-Cre system, also caused a moderate, but significant, increase in the T~reg~ cell frequency. Our finding is consistent with the previous observation and further suggests that TRAF3 may negatively regulate both the early development and the late-stage maturation or survival of T~reg~ cells. Interestingly, despite their increased T~reg~ cell frequency, the *Traf3^Treg-KO^* mice had impaired conventional T cell homeostasis, characterized by an increase in the percentage of CD4^+^ T cells with memory/effector surface markers. This result suggests a positive role for TRAF3 in the regulation of T~reg~ cell function. In contrast, the phenotype of the *Traf3^Treg-KO^* mice in T cell homeostasis is considerably weaker than that observed in mice lacking Foxp3 or other factors required for the development and core functions of T~reg~ cells. The *Traf3^Treg-KO^* mice also had only moderate immune cell infiltrations in the nonlymphoid tissues, particularly the lung. Consistently, adoptive transfer experiments revealed that the TRAF3-deficient T~reg~ cells had weakly reduced ability to suppress the expansion and pathogenesis of CD4^+^ T cells. We observed reduced expression of IL-10 in the TRAF3-deficient T~reg~ cells, which may contribute to their partially impaired function in maintaining immune homeostasis.

Despite the relatively weak phenotype in immune homeostasis, the *Traf3^Treg-KO^* mice had a prominent abnormality in antigen-stimulated GC reactions. In response to T-dependent antigens, these mutant animals formed enlarged GCs in the spleen and produced markedly more GC B cells, coupled with hyper production of high-affinity IgG subtypes. Gene expression analyses suggest the aberrant activation of T~FH~ cells. Of particular interest is the elevated production of various effector cytokines, including IL-4, IL-10, IL-17, and IFN-γ, by the T~FH~ cells derived from the immunized *Traf3^Treg-KO^* mice. Production of these cytokines by normal T~FH~ cells has been observed previously and thought to regulate B cell proliferation and antibody class switching ([@bib29]; [@bib18]; [@bib3]; [@bib23]). Thus, deregulated production of these effector cytokines by T~FH~ cells may contribute to the heightened GC formation and antibody responses in the *Traf3^Treg-KO^* mice. The aberrant T~FH~ cell activation was apparently caused by the defect of these mutant animals in producing T~FR~ cells. Upon immunization with a T-dependent antigen, the WT mice had a substantial increase in the T~FR~ cells, whereas the *Traf3^Treg-KO^* mice were severely attenuated in this response. In an adoptive transfer model, the TRAF3-deficient T~reg~ cells also displayed a severe defect in generating T~FR~ cells and suppressing GC responses. Under the transfer conditions, the TRAF3-deficient T~reg~ cells also had significantly reduced ability to suppress the production of T~FH~ cells. These results suggest that TRAF3 may regulate a signaling pathway in T~reg~ cells that is particularly important for their conversion into T~FR~ cells during an immune response.

The generation of T~FR~ cells from Foxp3^+^ T~reg~ cells is critically dependent on the transcription factor Bcl-6 ([@bib8]; [@bib20]; [@bib36]). Our data suggested that TRAF3 is not required for expression of Bcl-6 or the various T~reg~ cell signature molecules. Instead, TRAF3 appeared to be required for maintaining the high-level expression of ICOS in T~reg~ cells because the TRAF3 deficiency greatly reduced, although did not completely block, the expression of ICOS at both RNA and protein levels. By using an adoptive transfer approach, we obtained in vivo evidence that ICOS expression in T~reg~ cells is crucial for T~reg~ cell--mediated suppression of GC formation and antibody responses. Like the TRAF3-deficient T~reg~ cells, the ICOS-deficient T~reg~ cells were severely attenuated in the generation of T~FR~ cells and suppression of GC induction in response to immunization. These findings provide a mechanistic insight into the function of TRAF3 in regulating T~FR~ cell production and antibody responses. We believe that ICOS induction is an important, but probably not the only, mechanism by which TRAF3 regulates T~FR~ cell induction and antibody responses.

The signaling function of TRAF3 is complex and differs in different cell types and in the context of different receptors ([@bib14]). One important function of TRAF3 is to mediate degradation of NIK and, thereby, negatively regulate the noncanonical NF-κB signaling ([@bib19]). This negative signaling function of TRAF3 is particularly important for maintaining normal homeostasis and function of B cells, although its role in other cell types remains unclear ([@bib13]; [@bib37]; [@bib11]). Our data suggest that the activation of noncanonical NF-κB might contribute to the moderate defect of the TRAF3-deficient T~reg~ cells in maintaining CD4^+^ T cell homeostasis because perturbed CD4^+^ T cell homeostasis was also detected in mice with conditional expression of stable form of NIK (NIKΔT3^Treg-Tg^ mice). However, the noncanonical NF-κB activation is unlikely responsible for the functional defect of the TRAF3-deficient T~reg~ cells in the regulation of GC reactions. Unlike the TRAF3 deficiency, conditional expression of NIKΔT3 in T~reg~ cells did not cause hyperproduction of IgG or other antibody isotypes. The NIKΔT3-expressing T~reg~ cells did not show any defect in ICOS expression either. Instead, our data suggest a positive role for TRAF3 in mediating the TCR signaling in T~reg~ cells. As seen in conventional T cells ([@bib38]), the loss of TRAF3 in T~reg~ cells resulted in attenuated activation of the MAP kinase ERK. We obtained evidence that ERK is important for TCR-stimulated ICOS expression in T~reg~ cells.

In summary, we have identified TRAF3 as a signaling factor that mediates the effector function of T~reg~ cells, particularly in the control of humoral immune responses. Although TRAF3 is dispensable for the homeostasis of T~reg~ cells, it is crucial for antigen-stimulated production of T~FR~ cells. Our data suggest that the T~reg~ cell regulatory function of TRAF3 involves induction of the co-stimulatory molecule ICOS, which is the result of impaired ERK activation. Our study has also revealed the requirement of T~reg~ cell--specific ICOS in the induction of T~FR~ cells and the control GC responses. These findings not only establish a novel role of TRAF3 in the regulation of T~reg~ cell function and humoral immune responses, but also shed new light onto the signaling mechanism regulating the specific functions of T~reg~ cells.

MATERIALS AND METHODS
=====================

### Mice.

Foxp3-GFP-hCre BAC transgenic mice ([@bib39]; The Jackson Laboratory) were backcrossed for nine generations to the C57BL/6 background and then crossed with *Traf3*-floxed mice (C57BL/6 background; [@bib11]) to produce age-matched *Traf3^+/+^*Foxp3^GFP-hCre^ (termed WT) and *Traf3^fl/fl^*Foxp3^GFP-hCre^ (termed *Traf3^Treg-KO^*) mice. In some experiments, these mice were further crossed with the Rosa26-YFP Cre reporter (termed R26^YFP^; C57BL/6J background; The Jackson Laboratory) to generate WT and *Traf3^Treg-KO^* mice that express YFP in their T~reg~ cells (termed WT-R26^YFP^ and *Traf3^Treg-KO^*R26^YFP^ mice, respectively). The *Traf3*-floxed mice were also crossed with CD4-Cre (C57BL/6 background; The Jackson Laboratory) mice to produce mice harboring TRAF3 deletion in total T cells (called *Traf3^TKO^* mice). NIKΔT3 mice (C57BL/6 background; The Jackson Laboratory) express a stabilized form of NIK lacking the TRAF3-binding motif (NIKΔT3) from the Rosa26 locus under the control of a *lox*P-flanked stop cassette ([@bib32]). These mice were crossed with the Foxp3-GFP-hCre mice (backcrossed to C57BL/6 background) to generate T~reg~-conditional NIKΔT3 transgenic (NIKΔT3^Treg-Tg^) and internal WT control mice. B6.SJL (expressing the CD45.1 congenic marker), *Tcrb*/*Tcrd*-dKO, *Icos*-KO, and *Rag1*-KO mice (all in C57BL/6 background) were obtained from the Jackson Laboratory. For all experiments, WT littermates were used as controls. Mice were maintained in a specific pathogen--free facility of the University of Texas MD Anderson Cancer Center, and all animal experiments were performed in accordance with protocols approved by the Institutional Animal Care and Use Committee of the University of Texas MD Anderson Cancer Center.

### Cell preparation and flow cytometry analysis.

Mononuclear cells were isolated from the spleen and intestinal lamina propria as previously described ([@bib27]; [@bib6]). T~reg~ cells were purified by flow cytometric cell sorting based on their expression of CD25 and the YFP marker from WT-R26^YFP^ or Traf3^Treg-KO^-R26^YFP^ mice. Flow cytometric analyses and cell sorting were performed ([@bib27]) using a FACSCalibur (BD) and FACSAria (BD), respectively. For intracellular cytokine staining (ICS), cells were stimulated with 50 ng/ml PMA plus 750 ng/ml ionomycin for 4--6 h in the presence of 10 µg/ml monensin, and the fixed cells were incubated with the indicated antibodies and subjected to flow cytometry. FITC-conjugated anti-CD95 (BD); PE-conjugated anti--PD-1, anti-CD138, anti--Bcl-6, anti-CTLA4, and anti-CXCR3 (BD); allophycocyanin (APC)-conjugated anti-GL7 and anti-CXCR5 (BD Bioscience); and PE-Cy7--conjugated anti-CD8 and anti-CD4 (eBioscience) were used. Other antibodies were described previously ([@bib6]).

### Mouse immunization.

Age-matched WT and *Traf3^Treg-KO^* mice (6--8 wk old) were immunized i.p. with 2 × 10^9^ SRBCs (Cocalico Biologicals), 100 µl NP-KLH (1 mg/ml), or 100 µl NP-Ficoll (1 mg/ml) and sacrificed at the indicated times for analyzing serum antibody concentration and GC formation.

### Influenza viral infection.

WT and *Traf3^Treg-KO^* mice were subjected to intranasal infection with a nonlethal dose (25 tissue culture ID~50~ units in 25 µl PBS per mouse) of influenza virus A/PR8 (H1N1) under isoflurane anesthesia. Body weight change was monitored every another day for 13 d. On day 13, influenza-specific antibodies in the serum were detected by ELSIA as described previously ([@bib9]). In brief, ELISA plates were coated with influenza virus overnight at 4°C, blocked with 1% BSA in PBS, and then loaded with serum samples prediluted in 1% BSA. After 3 h of incubation, the plates were washed three times with PBST buffer, and the bound antibody was detected by with biotinylated goat anti--mouse antibody and streptavidin-HRP using TMB as substrate.

### Histology and GC analysis.

Organs were removed from sacrificed mice, fixed in 10% neutral buffered formalin, embedded in paraffin, and sectioned for hematoxylin-eosin staining. For GC formation analysis, SRBC-immunized mice were sacrificed after 10 d of immunization. Frozen spleen sections were fixed in methanol/acetone (2:1) for 10 min, followed by blocking for 30 min in a biotin- and serum-free SuperBlock buffer (Thermo Fisher Scientific). The GCs were detected using biotinylated peanut agglutinin (Vector Laboratories) followed by Alexa Fluor 594--conjugated streptavidin (Molecular Probes). The sections were mounted using an antiquenching agent (Vectashield; Vector Laboratories) and analyzed under a fluorescent microscope (DP70; Olympus). Panoramic pictures were taken and the GCs counted. The area and perimeter of each GC from each mouse (*n* = 3) were obtained using ImageJ software (National Institutes of Health). The area and perimeter are expressed in micrometers. GC B cells were analyzed by flow cytometry after staining with FITC-conjugated anti-CD95, PE-conjugated anti-B220, and APC-conjugated anti-GL7, and plasma B cells were analyzed similarly by staining with FITC-conjugated anti-B220 and PE-conjugated anti-CD138. For detecting T~FH~ cells, the cells were stained with FITC-conjugated anti-CD4, PE-conjugated PD-1, and APC-conjugated CXCR5, followed by permeabilization with a Foxp3 staining kit (eBioscience) and intracellular staining with PE-conjugated anti--Bcl-6. T~FH~ cells were detected similarly except the inclusion of intracellular staining with FITC-conjugated anti-Foxp3 or the GFP marker.

### ELISA.

For SRBC or NP-specific antibody detection, Nunc Immuno Plate MaxiSorp plates (Thermo Fisher Scientific) were coated with SRBC lysate, NP9-BSA, or NP26-BSA and incubated overnight at 4°C. After blocking with 1% BSA in PBS, the plates were incubated with serially diluted standard or samples and then with HRP-conjugated detection antibodies. After colorimetric reaction (tetramethylbenzidine; Moss), the absorbance at 450 nm was measured using an ELISA plate reader. For IL-10 detection, Nunc plates were coated with 1 µg/ml anti--IL-10 capture antibody in 50 mM sodium bicarbonate and incubated overnight at 4°C. The coated plates were incubated with supernatant of the T~reg~ cell culture and subjected to colorimetric detection as described above.

### Immunoblot and real-time quantitative RT-PCR.

Purified T~reg~ and CD4^+^ T cells were lysed in RIPA buffer supplemented with inhibitors of phosphatases and the proteases. For analyzing ERK phosphorylation, the cells were stimulated with agonistic anti-CD3 and anti-CD28 antibodies using a cross-linking method ([@bib28]) before lysis. The cell lysates were fractionated by SDS-PAGE and subjected to immunoblot assays with the indicated antibodies. For analyzing RNA expression, total cellular RNA was isolated and subjected to real-time quantitative RT-PCR assays as previously described ([@bib7]). The gene-specific primer sets are listed in [Table S1](http://www.jem.org/cgi/content/full/jem.20131019/DC1){#supp1}.

### Electrophoretic mobility shift assay (EMSA).

Nuclear extract preparation and EMSA were performed as described previously ([@bib10]) using ^32^P-radiolabeled oligonucleotide probes. The probes used were mouse ICOS AP1, 5′-TTCATCCATCTAGTCATTCATTTACGCATC-3′; and NF-Y, 5′-AAGAGATTAACCAATCACGTACGGTCT-3′.

### In vitro and in vivo T~reg~ cell suppression assays.

The in vitro T~reg~ cell suppression assay was performed as previously described ([@bib6]). In vivo T~reg~ cell assays were performed essentially as described previously ([@bib6]). For examining the in vivo roles of T~reg~ cells in the regulation of GC reactions, sorted CD4^+^CD62L^hi^CD44^lo^CD25^−^ naive T cells from B6.SJL mice (5--6 wk old) and sorted CD4^+^GFP^+^CD25^+^ T~reg~ cells from WT, *Traf3^Treg-KO^*, and *Icos*-KO mice (5--6 wk old) were intravenously transferred into *Tcrb*/*Tcrd*-dKO mice. Recipient mice were immunized with SRBC 2 d after adoptive transfer and sacrificed 14 d later for analyzing serum antibodies and lymphocyte populations.

### Antibody somatic hypermutation analyses.

WT and *Traf3^Treg-KO^* mice were immunized with SRBCs and sacrificed after 10 d for isolating GC B cells by flow cytometric cell sorting based on the B220^+^CD95^+^GL7^+^ surface markers. Somatic hypermutation was analyzed based on the W33 to L hotspot mutation, essentially as previously described ([@bib24]). In brief, V~H~186.2 transcripts were amplified by PCR using the V~H~186.2 (5′-GCTGTATCATGCTCTCTTG-3′) and CHγ-1 (5′-GGTGCTATCCGGTCCCTGAGT-3′) primer pairs, and the PCR products were inserted into the pGEM-T vector by TA cloning. Randomly picked cDNA clones were sequenced for identification of the W33 to L mutations.

### Statistical analysis.

Prism software (GraphPad Software) was used for two-tailed unpaired Student's *t* tests. P-values of \<0.05 or \<0.01 were considered significant and very significant, respectively.

### Online supplemental material.

Table S1 lists the gene-specific primers used for real-time RT-PCR analyses. Online supplemental material is available at <http://www.jem.org/cgi/content/full/jem.20131019/DC1>.
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